TY - JOUR
T1 - Prognostic factors for return to work in breast cancer survivors
AU - Tamminga, Sietske J.
AU - de Wind, Astrid
AU - Greidanus, Michiel A.
AU - Coenen, Pieter
AU - Friberg, Emilie
AU - Oldenburg, Hester
AU - Duijts, Saskia F. A.
AU - de Boer, Angela G. EM
N1 - Funding Information: We thank Jill Hayden, Karen Nieuwenhuijsen, and Carl Moons for their valuable comments and peer review. We also thank Kirsten A Ziesemer (University Library, Vrije Universiteit, Amsterdam, NL) for setting up the search strategy and carrying out the search. We also thank the Cochrane Work staff, Julitta Boschman (Managing Editor), and Jan Hoving (Co-ordinating Editor), for their editorial support and Joost Daams (Information Specialist) for peer review of the search strategy. We thank Jessica Sharp for copy-editing this protocol. Funding Information: Finical support from the Amsterdam Public Health Research Institute, Netherlands Publisher Copyright: Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2022/2/16
Y1 - 2022/2/16
N2 - Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. The primary objective is to systematically review and synthesise the literature on the association between sociodemographic, breast cancer-related, other health-related, personal, and work-related factors and return to work in the first 24 months after breast cancer diagnosis among those survivors having paid work at diagnosis.
AB - Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. The primary objective is to systematically review and synthesise the literature on the association between sociodemographic, breast cancer-related, other health-related, personal, and work-related factors and return to work in the first 24 months after breast cancer diagnosis among those survivors having paid work at diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=85124996484&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/14651858.CD015124
DO - https://doi.org/10.1002/14651858.CD015124
M3 - Review article
SN - 1465-1858
VL - 2022
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 2
M1 - CD015124
ER -